Austar Lifesciences Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
22.00
-45.00
127.00
371.00
34.00
2.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
28.00
-212.00
-288.00
-254.00
20.00
-17.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
92.00
-153.00
-128.00
-69.00
107.00
29.00
Cash Flow from Investing Activities
3.00
-65.00
-178.00
70.00
-75.00
-26.00
Cash Flow from Financing Activities
-91.00
177.00
150.00
76.00
-2.00
-18.00
Net Cash Inflow / Outflow
5.00
-41.00
-154.00
78.00
29.00
-15.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
0.00
1.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Austar Lifesciences Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
22.6320884884366
1308.9975399655
-1,286.00
-98.27%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
28.7568689747439
-646.135609373594
674.00
104.45%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
92.5363365100647
971.654302056376
-879.00
-90.48%
Cash Flow from Investing Activities
3.77309897191528
-440.87794107756
443.00
100.86%
Cash Flow from Financing Activities
-91.5366821272757
-340.106924483675
249.00
73.09%
Net Cash Inflow / Outflow
5.99575784904928
188.714580907102
-183.00
-96.82%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.22300449434495
-1.95485558803542
2.00
162.56%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 160.23% vs -19.65% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
92.54
-153.65
160.23%






